Synchronized Brain and Hand Stimulation After Stroke

Sponsor
Amit Sethi (Other)
Overall Status
Recruiting
CT.gov ID
NCT04502290
Collaborator
(none)
20
1
1
75
0.3

Study Details

Study Description

Brief Summary

Among the 795,000 individuals who sustain a stroke annually in the United States, 65% continue to experience moderate-to-severe impairments in one hand six months or more, which limits their ability to perform daily tasks. Currently there is dearth of understanding of the mechanisms of motor recovery after stroke. Understanding the mechanisms can potentially lead to the development of interventions to improve motor performance after stroke. The proposed study will examine how synchronously pairing brain and hand stimulation repeatedly affects the plasticity of the brain and motor performance after stroke. The knowledge gained from this study can be useful to develop interventions to improve hand movement after moderate-severe stroke.

Condition or Disease Intervention/Treatment Phase
  • Device: Combined Non-invasive brain stimulation and functional electrical hand stimulation
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
20 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Synchronized Brain and Hand Stimulation to Improve Hand Function After Stroke
Actual Study Start Date :
Oct 1, 2020
Anticipated Primary Completion Date :
Dec 31, 2025
Anticipated Study Completion Date :
Dec 31, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: Combined non-invasive brain and Functional Electrical Stimulation

In this arm of the study participants will receive repeated non-invasive brain stimulation synchronously paired with FES

Device: Combined Non-invasive brain stimulation and functional electrical hand stimulation
Participants will receive synchronously combined non-invasive brain stimulation (delivered via electrical/magnetic stimulation) with functional electrical stimulation (delivered via DS7A or Neuromove) of the weak hand

Outcome Measures

Primary Outcome Measures

  1. Box and block test [Baseline to 6 weeks]

    The Box and Block Test (BBT) measures unilateral gross manual dexterity and the ability to release objects. It is a quick, simple and inexpensive test. It can be used with a wide range of populations, including clients with stroke. The BBT is composed of a wooden box divided in two compartments by a partition and 150 blocks. The BBT administration consists of asking the participants to move, one by one, the maximum number of blocks from one compartment of a box to another of equal size, within 60 seconds. The box is oriented lengthwise and placed at the client's midline, with the compartment holding the blocks oriented towards the hand being tested. Participants first perform this test with their unaffected hand in order to practice and register baseline scores. Additionally, a 15-second trial period is permitted at the beginning of each side. Before the trial, after the standardized instructions are given to participants are advised that their fingertips must cross the partition when

Secondary Outcome Measures

  1. Motor evoked potential [Baseline to 6 weeks]

    Surface EMG electrodes (Ag-AgCl) will be applied to the belly of the affected EDC muscle and a reference electrode will be placed at the clavicle. The motor evoked potential (MEP) data will be collected by stimulating the targets in the grid at 2000 Hz with Signal software (CED, Cambridge, UK).

  2. Hand force [Baseline to 6 weeks]

    We will measure force production of the wrist and finger extensors (EDC) using two 34.09 kg load cells embedded in cushioned customized platforms. The height of the load cells can be altered to accommodate individual hand sizes. Participants will perform 5 trials of isometric wrist and finger extension movements against load cells for 10 seconds. The force data will be amplified by 5-20K and collected at 1000 Hz using Biopac amplifier and software (Biopac Systems Inc, Goleta, CA, USA). To allow for the deliberate increase to peak force as well as the tendency to drop off near the end of the 10-second interval, we will calculate force output over the central 5 second segment.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Male or female (either right or left handed) with unilateral hemiparesis after stroke;

  2. Stroke onset of at least six months prior to the time of participation;

  3. Ability to elicit motor evoked potential in the Extensor digitorum communis (EDC) muscle

  4. Ability to grasp, as indicated by a score of at least 1 (out of 2) on the finger mass flexion and cylindrical grasp items of Upper Extremity Fugl-Meyer scale

  5. age between 18-80 years

Exclusion Criteria:
  1. Presence of severe aphasia , measured by cognitive and/or language impairments that preclude the ability to follow simple instructions;

  2. Excessive spasticity of wrist and finger muscles, defined as a Modified Ashworth Score more than or equal to 3, which may limit the ability to open the hand/fingers;

  3. Diagnosis of neurological disorders other than stroke, which may confound the results;

  4. Has touch and proprioceptive sensory deficits determined via a score of 0 on the position sense section (section H) of the Fugl Meyer Upper Extremity assessment proprioception, which may limit the ability to report excessive amount of tingling due to hand stimulation

  5. History of seizure or epilepsy as the effects of TMS are not tested in individuals with seizures or epilepsy;

  6. Orthopaedic/musculoskeletal conditions (eg, arthritis) affecting the upper extremity, which may limit the ability to move the affected hand

  7. Presence of metallic implants in the head or neck for TMS;

  8. Currently or planning to become pregnant, as the effects of TMS are not tested not pregnant women;

  9. Difficulty maintaining alertness or remaining still for MRI;

  10. Ferromagnetic metallic implants, pacemakers, other implanted devices, or ventilators (for MRI);

  11. Bodyweight > 300 lbs due to MRI scanner dimensions

  12. Psychiatric diagnosis according to the criteria of the Diagnostic and Statistical Manual of Mental Disorder, Fifth Edition (DSM-V), or who are on psychotropic medication, which may confound the results

  13. Cognitive impairments, defined as a score of < 23 on the Mini Mental Status Examination, which may limit the ability to follow the commands in the study

  14. Excessive pain > equal to 5 on Visual Analog Scale in the more-affected upper extremity, which may limit the ability to participate in the study

  15. History of schizophrenia, Bipolar disorder (type I or II) [Answer yes to questions 16 and items of the (hypo) maniac module of the The Mini International Neuropsychiatric Interview], current moderate, severe depression (Scores of >10 on Patient Health Questionnaire-9) and other neurological or medical conditions that could confound results.

  16. Life expectancy less than the duration of the study

  17. Hemispatial neglect, which may limit the ability to pay attention to the affected hand

  18. Participating in concurrent therapy, which may confound the results

  19. We will exclude children because although stroke may occur in children, the protocol is addressing stoke in adults and the devices are not approved for use in children

Contacts and Locations

Locations

Site City State Country Postal Code
1 Neuromotor Recovery and Rehabilitation Lab Pittsburgh Pennsylvania United States 15260

Sponsors and Collaborators

  • Amit Sethi

Investigators

  • Principal Investigator: Amit Sethi, UPitt

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Amit Sethi, Assistant Professor, University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT04502290
Other Study ID Numbers:
  • STUDY19070157
First Posted:
Aug 6, 2020
Last Update Posted:
Aug 3, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 3, 2022